TP53 and neoplasm: TP53 is a well-known biomarker of a poor prognosis and unfavorable response to ICI, B2M loss leads to impaired antigen presentation via MHC, and STAT3 and STAT6 are responsible for creating an immunologically exhausted tumor microenvironment [41,43,46,47,64,65].